Agennix AG is a publicly listed biopharmaceutical company. The Company’s clinical development programs include oral talactoferrin alfa; a topical gel form of talactoferrin and RGB-286638, a multi-targeted kinase inhibitor. Agennix’s registered seat is in Heidelberg, Germany. The Company’s site of operation is in Princeton, New Jersey.
Agennix currently has no open positions.
Note: With the submission of your application you agree to your application papers being preserved for a period of up to 9 months.
Disclaimer: This site does not accept resumes from third party vendors. Third party vendors will not be compensated for their referral of candidates to Agennix.